Aktive Positionen von Kristian Strømgaard
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Avilex Pharma ApS
 Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Vorstandsvorsitzender | 27.12.2012 | - |
| Gründer | 27.12.2012 | - | |
| Direktor/Vorstandsmitglied | 27.12.2012 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 25.03.2014 | - |
Karriereverlauf von Kristian Strømgaard
Statistik
International
| Dänemark | 2 |
Operativ
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Avilex Pharma ApS
Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Börse
- Insiders
- Kristian Strømgaard
- Erfahrung
